Search General Info
Search Education
Search Partnering Companies

Kenneth Mandell, MD, PhD

Lexington, Massachusetts, United States
Dr. Mandell is the Founder and CEO of LayerBio and an expert in the field of ocular drug delivery. A Harvard-trained ophthalmologist and serial entrepreneur, he previously served as CMO at Neurotech Pharmaceuticals and Noveome Biotherapeutics, and prior to that he was Acting VP of Medical Affairs at Aldeyra Therapeutics. He is co-inventor of Oyster Point Pharma’s OC-01
treatment for dry eye disease and Aldeyra’s reproxalap eye drop for ocular inflammation. He is
currently a strategic advisor to Kato Pharmaceuticals, Regenerate Therapeutics and Aramis Biosciences. He previously served as a consultant to multiple ophthalmology-focused companies, including Eloxx Pharmaceuticals, Aciex Therapeutics, Clearside Biomedical and Envisia Therapeutics. He is currently the medical monitor for more than a dozen studies at the National Eye Institute.
Speaking In
[On Demand]

LayerBio is a clinical-stage biotech company developing its novel OcuRing™ technology for…